PRIMA, a new Center of Excellence received funding!

We're very proud to be a part of Precision Immunotherapy Alliance, "PRIMA"

PRIMA is a new Center of Excellence (CoE) / Sentre for fremragende forskning (SFF) recently founded by The Research Council of Norway. The new center is one of nine CoEs, and has received NOK 155 million in funding.

The alliance is made up of seven research group leaders from Oslo University Hospital and the University of Oslo. We look forward to working together with the excellent team of researchers on developing a cancer treatment that can be used to cure several forms of cancer. The goal is to create a set of tailor-made therapy cells in order for it to be possible to handpick the form of treatment that best suits the individual patient.

Congratulations to the project leaders: Karl-Johan Malmberg, Johanna Olweus and the entire team: Ludvig A Munthe, Fridtjof Lund-Johansen, June Myklebust, Jan Terje Andersen and our group leader Emma Haapaniemi.

Read the full press release (in Norwegian).

Alliance group members

In the photo above you can see (from left to right): Jan Terje Andersen, Ludvig A Munthe, Emma Haapaniemi, June Myklebust, Karl-Johan Malmberg, Fridtjof Lund-Johansen. 

(Photo credit: Jan Terje Andersen)

Latest news

We had the pleasure of attending the 41st NSI Annual Meeting on November 24th, 2023!
We're excited to present our newest publication, published in the STAR Protocols journal in December 2023.
His lecture was titled “Kurativ behandling av monogenetiske sykdommer med genterapi. En ny tidsalder?” (Curative treatment of monogenetic diseases with gene therapy. A new age?).
We're looking for a specialist with a background in stem cell research to join our group!
A new opportunity to work in our research group!